Phase II study of recombinant gamma-interferon in patients with advanced nonosseous sarcomas.
D000328:Adult; D000368:Aged; D004274:DNA, Recombinant; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D007371:Interferon-gamma / Q000009:adverse effects / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D012509:Sarcoma / Q000401:mortality / Q000473:pathology / Q000628:therapy*
D004274:DNA, Recombinant; D007371:Interferon-gamma